- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Avian influenza virus.
Displaying page 1 of 1.
EudraCT Number: 2007-002480-27 | Sponsor Protocol Number: V87P6 | Start Date*: 2007-08-15 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | |||||||||||||
Full Title: A Phase II, Randomized, Controlled, Observer-blind, Single-center Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Subjects aged 6 month... | |||||||||||||
Medical condition: avian influenza | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001683-29 | Sponsor Protocol Number: 114464 | Start Date*: 2015-06-03 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | ||||||||||||||||||
Full Title: A Phase 2/3, randomized, controlled, observer-blind, multi-center trial to evaluate the safety and immunogenicity of a two-dose primary vaccination series of monovalent A/Indonesia/5/2005 (H5N1) va... | ||||||||||||||||||
Medical condition: Healthy volunteers (immunization against avian influenza virus A (H5N1) infection) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003512-23 | Sponsor Protocol Number: 114495 | Start Date*: 2015-06-03 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | ||||||||||||||||||
Full Title: A phase II, randomized, observer blind, multicenter study to evaluate the safety and immunogenicity of a single low dose of AS03-adjuvanted, Quebec- or Dresden- manufactured monovalent A/California... | ||||||||||||||||||
Medical condition: Healthy volunteers (immunization against A/California/7/2009 (H1N1)v-like influenza) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-005203-33 | Sponsor Protocol Number: V87P3 | Start Date*: 2006-11-16 |
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | ||
Full Title: A Phase II, Multicenter, Exploratory Study to Evaluate Safety and Immunogenicity of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adults Unprimed and Primed with MF59-adjuvanted or Non-adjuvanted H5... | ||
Medical condition: avian influenza | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002712-25 | Sponsor Protocol Number: V101P1 | Start Date*: 2007-10-29 |
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | ||
Full Title: A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study on the Safety and Immunogenicity of Novartis Tetravalent Influenza Vaccine (containing both interpandemic strains and ... | ||
Medical condition: Avian Influenza | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005428-18 | Sponsor Protocol Number: V87P4 | Start Date*: 2007-01-19 |
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | ||
Full Title: A Phase III, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subj... | ||
Medical condition: avian influenza | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-000115-28 | Sponsor Protocol Number: 109817 | Start Date*: 2007-07-16 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, open, non-randomized study designed to evaluate the reactogenicity and immunogenicity of one or two booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in a... | ||
Medical condition: Since 1997, avian H5N1 influenza has caused several human infections and high mortality rate in Southeast Asia. Experts warn that the next influenza pandemic is imminent and could be severe. Preven... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
